PRESS RELEASE published on 04/09/2025 at 07:00, 1 year 6 months ago Valneva and LimmaTech Announce First Vaccination in Phase 2 Infant Study of Tetravalent Shigella Vaccine Candidate S4V2 Valneva and LimmaTech announce first vaccination in Phase 2 infant study of tetravalent Shigella vaccine candidate S4V2. Study aims to combat shigellosis, a deadly diarrheal disease Valneva Phase 2 Study Shigella Vaccine Shigellosis LimmaTech
PRESS RELEASE published on 04/09/2025 at 06:59, 1 year 6 months ago Biophytis Confirms the Launch of the Phase 2 OBA Clinical Trial in Obesity Biophytis confirms the launch of the Phase 2 OBA Clinical Trial in Obesity in 2025. The study aims to evaluate the efficacy of BIO101 in reducing muscle strength loss caused by GLP-1 agonists in obese patients Biophytis BIO101 Obesity Muscle Strength Phase 2 OBA Clinical Trial
PRESS RELEASE published on 04/09/2025 at 06:40, 1 year 6 months ago Bondholder meetings approve amendments proposed by MBT Systems GmbH and Meyer Burger Technology AG Bondholder meetings approve proposed amendments by MBT Systems GmbH and Meyer Burger Technology AG for 2027 and 2029 convertible bonds, exceeding required threshold Convertible Bonds Amendments Meyer Burger Technology AG Bondholder Meetings MBT Systems GmbH
PRESS RELEASE published on 04/09/2025 at 06:30, 1 year 6 months ago First trading day of Cham Swiss Properties Cham Swiss Properties AG debuts on SIX Swiss Exchange after successful merger, now one of Switzerland's top real estate companies with CHF 1.6 billion portfolio. Targets sustainable growth and dividend distribution Merger Real Estate Portfolio Growth SIX Swiss Exchange Cham Swiss Properties AG
PRESS RELEASE published on 04/09/2025 at 04:00, 1 year 6 months ago QNX Now Powering WeRide's Next-Generation ADAS Platform QNX and WeRide collaborate to accelerate Software Defined Vehicles deployment for automotive industry with advanced ADAS technology integrated into Chery's EXEED Sterra ES and ET models in China QNX Chery Software Defined Vehicles WeRide ADAS Technology
PRESS RELEASE published on 04/08/2025 at 23:45, 1 year 6 months ago Redcare successfully executes placement of new convertible bonds and buys back part of the outstanding convertible bonds. Redcare Pharmacy N.V. successfully executes placement of new convertible bonds amounting to EUR 300 million with a maturity of seven years and buys back a part of outstanding convertible bonds, strengthening its balance sheet and capital structure Convertible Bonds Debt Financing Capital Structure Redcare Pharmacy N.V. E-Pharmacy
PRESS RELEASE published on 04/08/2025 at 23:21, 1 year 6 months ago EQS-Adhoc: Redcare Pharmacy N.V. successfully places EUR 300 million convertible bonds and repurchases part of its outstanding EUR 225 million 0.00% convertible bonds due 2028 Redcare Pharmacy N.V. successfully places EUR 300 million convertible bonds and repurchases part of its outstanding EUR 225 million 0.00% convertible bonds due 2028. The company intends to use the net proceeds for general corporate purposes Convertible Bonds Repurchase Redcare Pharmacy N.V. EUR 300 Million Financial Financing
PRESS RELEASE published on 04/08/2025 at 22:58, 1 year 6 months ago EQS-Adhoc: Semperit AG Holding: US tariff policy and lower global order activity lead to adjustment of EBITDA guidance for 2025 – Guidance 2026 suspended due to current high uncertainties Semperit AG Holding adjusts EBITDA guidance for 2025 due to US tariffs and lower global order activity. Guidance for 2026 suspended EBITDA Guidance Semperit AG Holding 2025 US Tariffs Global Order Activity
PRESS RELEASE published on 04/08/2025 at 22:47, 1 year 6 months ago MicroVision Announces Retail Investor Day in Redmond, WA on May 20, 2025 MicroVision, Inc. to host MicroVision Retail Investor Day on May 20, 2025 in Redmond, WA. Shareholders can interact with executive team and view product demos Executive Team MicroVision Retail Investor Day Redmond Product Demos
PRESS RELEASE published on 04/08/2025 at 22:30, 1 year 6 months ago Forte Group Announces Strategic Initiatives to Strengthen Financial Position Forte Group Holdings Inc. plans to settle debts with shares, cancels marketing agreement with Aktiencheck. Details on strategic financial decisions and future outlook disclosed Debt Settlement Financial Strategy Future Outlook Forte Group Holdings Inc. Marketing Agreement Cancellation
Published on 10/23/2026 at 02:20, 8 hours 6 minutes ago Apex Announces Nasdaq Listing and Pricing of US$1.86 Million Offering
Published on 10/22/2026 at 23:30, 10 hours 56 minutes ago Cypher Announces Subscription Receipt Offering
Published on 10/22/2026 at 22:30, 11 hours 56 minutes ago Unusual Machines to Announce Third Quarter 2026 Financial Results and Provide Corporate Update
Published on 10/22/2026 at 16:00, 18 hours 26 minutes ago Future Fuels Announces Closing of Brokered Offering for Gross Proceeds of C$6.6 Million
Published on 10/22/2026 at 14:30, 19 hours 56 minutes ago Unusual Machines Receives $16.9 Million Purchase Order from Powerus for American-Made Drone Components
Published on 10/23/2026 at 10:18, 7 minutes ago Schirp Schjmidt-Morsbach Rechtsanwälte PartG: Investor Lawsuits in the Wirecard Case: Federal Court of Justice Dismisses EY from Model Proceedings The lead plaintiff’s attorneys welcome the decision
Published on 10/23/2026 at 10:05, 21 minutes ago SINEXCEL Achieves IEC 62443-4-1 Certification for Cybersecurity Compliance
Published on 10/23/2026 at 09:00, 1 hour 26 minutes ago Municipality Finance issues a USD 135 million tap under its MTN programme
Published on 10/23/2026 at 09:00, 1 hour 26 minutes ago Original-Research: THE NAGA GROUP AG (von NuWays AG): BUY
Published on 10/23/2026 at 07:00, 3 hours 26 minutes ago Safran publie son chiffre d’affaires du 3e trimestre 2026
Published on 10/22/2026 at 18:00, 16 hours 26 minutes ago THERMADOR GROUPE : Completion of the share buy-back programme launched in August
Published on 10/22/2026 at 18:00, 16 hours 26 minutes ago THERMADOR GROUPE : Fin du programme de rachat d’actions débuté en août
Published on 10/22/2026 at 18:00, 16 hours 26 minutes ago bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics